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INVESTIGATION

Multiplex shRNA Screening of Germ Cell
Development by in Vivo Transfection of
Mouse Testis
Nicholas R. Y. Ho,*,1 Abul R. Usmani,*,1 Yan Yin,† Liang Ma,† and Donald F. Conrad*,2

*Department of Genetics and †Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
ORCID ID: 0000-0003-3828-8970 (D.F.C.)

ABSTRACT Spermatozoa are one of the few mammalian cell types that cannot be fully derived in vitro, severely
limiting the application of modern genomic techniques to study germ cell biology. The current gold standard
approach of characterizing single-gene knockout mice is slow as generation of each mutant line can take 6–
9 months. Here, we describe an in vivo approach to rapid functional screening of germline genes based on a
new nonsurgical, nonviral in vivo transfection method to deliver nucleic acids into testicular germ cells. By
coupling multiplex transfection of short hairpin RNA (shRNA) constructs with pooled amplicon sequencing as
a readout, we were able to screen many genes for spermatogenesis function in a quick and inexpensive
experiment. We transfected nine mouse testes with a pilot pool of RNA interference (RNAi) against well-characterized genes to show that this system is highly reproducible and accurate. With a false negative rate of 18%
and a false positive rate of 12%, this method has similar performance as other RNAi screens in the well-described
Drosophila model system. In a separate experiment, we screened 26 uncharacterized genes computationally
predicted to be essential for spermatogenesis and found numerous candidates for follow-up studies. Finally, as a
control experiment, we performed a long-term selection screen in neuronal N2a cells, sampling shRNA frequencies at ﬁve sequential time points. By characterizing the effect of both libraries on N2a cells, we show that our
screening results from testis are tissue-speciﬁc. Our calculations indicate that the current implementation of this
approach could be used to screen thousands of protein-coding genes simultaneously in a single mouse testis.
The experimental protocols and analysis scripts provided will enable other groups to use this procedure to study
diverse aspects of germ cell biology ranging from epigenetics to cell physiology. This approach also has great
promise as an applied tool for validating diagnoses made from medical genome sequencing, or designing
synthetic biological sequences that can act as potent and highly speciﬁc male contraceptives.

As the carrier of genetic information from one generation to the next,
germ cells are derived from one of the most specialized developmental
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processes in the body. Once the stem cell commits to the terminal sperm
lineage, it has to trigger various transcription factors to begin specialized
metabolic processes, produce haploid cells via meiosis, tightly pack the
genomic DNA, and prepare for functions like ﬂagellum motion, cell
recognition, and acrosome formation. Furthermore, some of the pathways for core physiological processes are distinct from somatic cells
despite having similar functions (Eddy 1998). Perhaps due to this richness, the study of mammalian spermatogenesis has led to numerous
seminal discoveries with broad implications in areas of biology such as
stem cells (Chen et al. 2005), transposable elements (Girard et al. 2006),
adaptive evolution (Carelli et al. 2016), and speciation (Good et al.
2010).
Despite the opportunities for discovery in the ﬁeld of spermatogenesis, the pace of progress has been limited because existing in vitro model
systems are technically challenging to implement (Stukenborg et al.
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2009; Sato et al. 2011; Dores and Dobrinski 2014). Generation of
knockout mouse models has thus been the most popular tool to characterize the function of genes in germ cells. Due to the high cost (over
$5000 USD) and the time involved (over 1 yr) in deriving a colony of a
new mouse line, the “one-gene, one-mouse” approach cannot be easily
used to perform systematic screens of the genome. This limited access
to high-throughput screening in germ cells is a stark contrast to the
rapid expansion of multiplex genomic techniques now being used in
cell lines (ENCODE Project Consortium 2012). As these large-scale,
multiplex genomic studies become more commonplace, the gap between our knowledge of germ cell and somatic cell biology will only
grow if single-mutation mouse models remain the method of choice.
To address this problem, we have developed a quick, simple, and
inexpensive method to screen numerous genes simultaneously in vivo
for spermatogenesis function. The mammalian testis continuously produces millions of mature sperm each day. This abundance of testicular
germ cells would easily support a multiplex genomics screen like those
used in cell lines if one could develop a viable way to deliver nucleic
acids into the testis of a living animal. The basis for our approach is a
novel method for direct transfection of testicular germ cells, coupled to
the popular RNAi screen, a mature technology commonly used to
efﬁciently elucidate gene function. RNAi screens have been used in cell
lines (Luo et al. 2008; Zuber et al. 2011b) or in vivo (Zender et al. 2008;
Bric et al. 2009; Meacham et al. 2009; Zuber et al. 2011a; Beronja et al.
2013; Wuestefeld et al. 2013) in somatic tissues to discover important
genes for a variety of biological processes.
Here, we demonstrate the feasibility of using this low-cost transfection method in mouse testes to screen multiple genes simultaneously
for functional importance in spermatogenesis. By carefully designing the
pilot study, we were also able to benchmark this system to prove the
importance of large numbers of biological replicates and quantify the
limits of this system. We also applied this method to establish the
functional importance of 26 uncharacterized genes that we previously
predicted to be important for infertility via machine learning (Ho et al.
2015).
MATERIALS AND METHODS
Gene selection
To design the pilot pool, we used data from the Mouse Genome Database
(Eppig et al. 2015) from Jackson Labs (MGI) to create a list of genes that
affect the male reproductive system when knocked out. We then used a
list of genes that have been knocked out and not reported to cause any
male reproductive defects to use as negative controls. For the predicted
spermatogenesis gene pool, we picked the top 30 candidates from each
of the mouse predicted infertility gene models (Ho et al. 2015) and
ﬁltered it to keep only the genes for which knockout mouse lines were
not available based on the Jackson Labs MGI website. We then selected
shRNAs against three of the known negative genes from the pilot pools
together with two scrambled nonmammalian sequences to use as negative controls.
shRNA pool preparation
We used RNAi from the MISSION TRC-Mm 1.5 and 2.0 (Mouse)
obtained from Sigma-Aldrich (see Supplemental Material, Table S1)
ordered as shRNA plasmids. The shRNA expression cassette from the
plasmids was ampliﬁed from the plasmid pool by PCR and puriﬁed
using AMPure XP beads (see File S2). These puriﬁed amplicons were
pooled and then used for injection into mouse testis and transfection
into cell lines. An aliquot of this mixture was sequenced on MiSeq to
determine the initial shRNA pool composition.
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shRNA validation
Over half (65/121) the shRNAs in the pilot pool and about a third of the
shRNAs (48/145) in the predicted gene pool were reported by SigmaAldrich to be validated in various cell lines (see Table S1). There was at
least one validated shRNA for 72% (18/25) of the pilot pool genes and
45% (13/29) of the predicted pool genes. While not all the validated
shRNAs were consistently signiﬁcantly depleted in the two studies,
many of them were, giving us conﬁdence that the signal we observed
was not caused by off-target effects.
Mouse testis transfection
We performed the experiments using C57BL/6 mice generated in-house
between 28–32 d of age. All mice were maintained under pathogen-free
conditions and all animal experiments were approved by Washington
University’s Animal Studies Committee. Each mouse received bilateral
intratesticular DNA injections ﬁve times, spaced 3–4 d apart (see File
S1). Following the injections, the mice were allowed to recover until
20 d after the third injection, when testes were dissected. Genomic
DNA from the whole testis was extracted using a QIAGEN DNeasy
Blood and Tissue kit.
Cell line transfection
N2a cells were seeded at a density of 0.3 · 106 in 6-well cell culture plates.
Cells were maintained in Dulbecco’s Minimum Essential Media
(DMEM; GIBCO) supplemented with 10% heat inactivated Fetal Bovine Serum (FBS; GIBCO) and 1% penicillin-streptomycin (Pen-Strep;
GIBCO) until they reached 70% conﬂuency in 6-well cell culture plates.
Each well of cells was transfected with 2.5 mg shRNA pool DNA using
Lipofectamine 3000 (Life Technologies) following the manufacturer’s
instructions. The cells were then maintained at 37 with 5% CO2 for
12 d, splitting at a ratio of 1:20 every 2 d with daily media replacement.
At each passage, remaining cells after splitting were harvested and
genomic DNA was extracted from them using the QIAGEN DNeasy
Blood and Tissue Kit.
Immunoﬂuorescence assays
Testis tissues were ﬁxed in 4% paraformaldehyde diluted in PBS overnight. Following that, they were ﬂushed in PBS three times for 1 hr each,
followed by a ﬂush in 30% ethanol for 1 hr, 50% ethanol for 1 hr, and ﬁnally
70% ethanol for 1 hr. Processing of the tissue was carried out in serial
ﬂushing as follows: 70% ethanol for 5 min, 70% ethanol for 45 min, 80%
ethanol for 45 min, 95% ethanol for 45 min, 95% ethanol for 45 min, 100%
ethanol for 1 hr, 100% ethanol for 1 hr, xylene for 1 hr, xylene for 1 hr,
xylene for 1 hr, parafﬁn for 1 hr, and parafﬁn for 75 min. Tissues were then
embedded in parafﬁn blocks and sectioned at 5 mm thickness. Slides were
boiled for 20 min in antibody retrieval solution (10 mM sodium citrate
and 0.05% Tween20, pH 6.0) and stained with goat anti-GFP primary
antibody (Abcam: ab5450) diluted 1:1000 in blocking solution (1 · PBS,
0.2% Triton X, and 5% Donkey serum) overnight at 4. A secondary
antibody staining was performed using CF594 donkey anti-goat (Biotium: 20116) diluted 1:300 in blocking solution for 1.5 hr at room temperature. Hoeschst 33342 (Life Technologies: H3570) was diluted 1:500
in water and added to the slides for 5 min just before visualization.
Illumina sequencing library preparation
We used a custom protocol to amplify the shRNA sequences in the
genomic DNA samples (see File S2). This protocol used two rounds of
PCR ampliﬁcation to prepare the sequencing library instead of ligation
followed by PCR ampliﬁcation. We started with 2 mg of genomic DNA
to survey the genomes of enough cells in order to reduce the likelihood

of dropout or PCR jackpotting; common artifacts when testing low
numbers of cells.
Each biological sample had between three to ﬁve separate sequencing
libraries prepared with different indices using different aliquots of genomic DNA to quantify technical noise. Sequencing libraries were then
pooled and run in a lane of Illumina MiSequation 2 · 150 bp to obtain an
average of at least 3000 reads per unique shRNA in the library.
Statistical analysis
Mapping of reads to shRNAs was done by aligning each read to the
unique half of the hairpin sequence with no mismatches. A table of read
counts for each shRNA was generated to determine signiﬁcant enrichment/depletion. There was no signiﬁcant difference in the counts between paired-end reads when they were mapped separately.
We minimized technical noise by using the median value of technical
replicates as the true count for each shRNA.
To determine signiﬁcant depletion/enrichment of shRNAs, we
used a custom R script (File S3). We started by normalizing the
shRNA count data to the number of reads per shRNA per million
reads in the sequencing library. We then calculated the log 2 fold
enrichment of each shRNA in the testis relative to the initial DNA
pool. The fold changes of different experiments using the same
shRNA pool design were always normalized to the sequencing
counts of the actual injected material. These fold changes were then
merged to produce more biological replicates for a given shRNA
pool design. Finally, we performed a Wilcoxon Rank Sum test for
each shRNA’s fold enrichment across biological replicates against
the fold enrichment of shRNAs against genes that are not known to
affect spermatogenesis, to calculate the likelihood that the shRNA
was signiﬁcantly depleted or enriched compared to the null. Any
shRNA that had a P-value smaller than the cutoff was determined to
be signiﬁcant. Due to the low transfection efﬁciency (1–3%) (see
Table S1), multiplicity of infection, a common issue in RNAi
screens, was not a worry in the analysis.
Network analysis
We performed a functional pathway analysis of the genes targeted in the
Predicted Genes screen and found four functional networks. We built
networks based on coexpression, protein–protein interactions, shared
protein domains, and colocalization. We used Cytoscape (Shannon
et al. 2003) with the GeneMANIA plugin (Montojo et al. 2010) with
the default settings to visualize the functional network of the tested
predicted genes.
Data and reagent availability
The raw sequencing data supporting the conclusions of this article
are available in the Short Read Archive under accession number
SRP069249. Table S1 provides a detailed description of the design
and clone name for every shRNA construct used in the study. Table
S3 and Table S4 provide normalized screening results for each
shRNA construct. Table S5 provides the raw read counts for every
shRNA construct from every experiment. The code that was used to
analyze these raw reads counts and produce the results in this paper
is provided in File S3.
RESULTS
In vivo transfection
Recently, a small number of studies have shown that one can use viruses
to transfect mouse tissues in vivo with a sufﬁciently high transfection
rate for multiplex selection experiments (Beronja et al. 2013;

Wuestefeld et al. 2013). One of us (A.U.) recently developed a novel
method for direct transfection of testicular germ cells that provides a
nonviral, nonsurgical alternative for nucleic acid delivery. This technique uses a buffered salt solution to generate an osmotic gradient that
drives water and dissolved linear DNA into the germ cells of the testis at
a reasonably high rate (Usmani et al. 2016). Once inside the cells, the
DNA integrates spontaneously and randomly into the genome at a
concentration-dependent rate, presumably through nonhomologous
end joining during routine DNA repair. We adapted this approach to
transfect the germ cells in the testis to render it compatible with linear
DNA libraries expressing shRNAs (Materials and Methods, Figure 1).
Visual inspection of testes transfected with a GFP reporter indicated
that both somatic and germ cell types receive construct, but that germ
cells, which comprise well over 75% of the adult testis, are preferentially
transfected (Figure 2). By integrating the expression cassette into the
genome, we achieved stable expression of the RNAi construct in transfected cells that could persist for weeks and could be observed in germ
cells spanning all stages of spermatogenesis (Figure 2).
Pilot shRNA screen
In order to optimize the screening technique, we designed a pilot shRNA
pool targeting three classes of genes: (i) sixteen genes that have been
shown to cause assorted dosage-dependent defects of sperm development when inactivated and/or overexpressed (BAX, CSF, KIT, PIN1,
CPEB1, GNPAT, MLH3, SPO11, CIB1, MAP7, PYGO2, TBPL1, SH2B1,
TSN, SIRT1, VAMP7, and VDAC3); (ii) ﬁve genes that have been
characterized with knockout mice but have not been linked to spermatogenesis defects (MMP3, SYT4, TFF3, TNFSF4, and TYRP1); and
(iii) three genes that have not been characterized in a mouse model and
are not expressed in mouse testis (APOC4, LCE1I, and SCRG1). Our
pool contained 119 unique RNAi constructs with a mode of ﬁve RNAi
constructs per targeted gene (see Table S1).
Using the pilot pool, we ﬁrst benchmarked the infection efﬁciency of
our novel osmotic gradient transfection buffer (“Tris-HCl + DNA”)
against the current gold standard for in vivo screening, lentiviral infection. To enable rapid measurement of infection efﬁciency, we
designed a qPCR assay for DNA copy number of the shRNA constructs, calibrated to actin (see Figure S1). We compared the infection
rate of a single injection of high-titer virus (109 Titer unit/ml) against
either a single injection of Tris-HCl with 15 mg DNA, or a single injection of Tris-HCl + DNA followed by four “booster” shots of additional 15 mg aliquots of shRNA library separated 3–4 d apart (Materials
and Methods). A single injection of high-titer lentivirus produced a
testis with a higher infection rate than a single injection of Tris-HCl
with 15 mg of DNA (see Table S2). However, the single injection of
lentivirus produced an infection rate that was lower than ﬁve injections
of the Tris-HCl + DNA (0.1% vs. 1–4%). Due to the lower infection rate,
we observed low reproducibility and more dropout of shRNA constructs in the single DNA and viral injection testes samples compared
to the ﬁve DNA injection testes. Since the cost of performing ﬁve DNA
injections is signiﬁcantly lower than even one high-titer lentivirus injection (about $50 vs. $250), we decided to proceed with the direct DNA
injections rather than attempt multiple lentiviral injections.
Next, we transfected the pilot library into nine mouse testes using the
ﬁve-shot protocol in order to perform a screen for genes required for
germ cell differentiation. After transfection, we waited 20 d, slightly
longer than half of one cycle of spermatogenesis, before recovery and
quantiﬁcation of the shRNA library from the testes. We extracted total
genomic DNA from each testis, and used PCR to create at least three
replicate sequencing libraries from each testis (Materials and Methods,
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Figure 1 Overview of experimental approach. A short hairpin RNA
(shRNA) library is designed against
20–30 genes, comprising 3–5 distinct constructs per gene. For a
typical library, three types of genes
are selected: positive controls
(genes known to be essential for
spermatogenesis), negative controls (genes not thought to have a
testis phenotype when biallelically
inactivated), and “test” genes
whose role in spermatogenesis is
uncertain and to be determined
in the screen. This library is maintained as a pool of plasmids, each
plasmid bearing one shRNA construct. DNA from the input pool is
isolated and split into two aliquots:
one for quantiﬁcation and one for
transfection. The transfection aliquot is delivered to the testis using
our nonsurgical approach (Materials and Methods). After 20–30 d
following transfection, the DNA
from germ cells are isolated and
shRNA-speciﬁc primers are used
to create sequencing libraries from
both the input pool and the posttestis pools. Sequencing libraries
are then sequenced using short-read sequencing and the relative abundance of each shRNA construct in a library can be estimated by counting
the sequencing reads containing that shRNA construct. The effect of a gene knockdown on spermatogenesis is summarized as the log2 fold
change of shRNA abundance in the post-testis pool compared to the input pool. The screen is designed to be used in combination with any cell
selection scheme; for instance, libraries can be made from puriﬁed subpopulations of germ cells to identify stage-speciﬁc effects. In the present
study, we largely report results from post-testis libraries made from total testis DNA.

Figure S2). A control library was also made from an aliquot of the input
shRNA pool that was not injected into testis. The frequency estimates
of individual shRNAs were very strongly correlated among biological
replicates (Pearson correlations 0.66–0.96, Figure 3).
We devised an analysis strategy to identify shRNAs that were
signiﬁcantly depleted in the post-testis shRNA library when compared

Figure 2 Expression of a transgene delivered directly to testicular germ
cells with Tris-HCl transfection. (A) a C57Bl/6J mouse testis injected
three times with 15 mg of a plasmid constitutively expressing GFP via a
CMV promoter dissolved in 150 mM Tris-HCl with 3–4 d between each
injection. Using an anti-GFP antibody, GFP was observed in numerous
germ cell subtypes including spermatids, spermatocytes, and spermatogonia. (B) an adjacent section of the same testis, processed without
primary antibody against GFP. The scale bar on the bottom right indicates 50 mm in length. Blue indicates Hoechst 33342 and green indicates GFP. CMV, cytomegalovirus; GFP, green ﬂuorescent protein.
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to the input library (Materials and Methods, Table S3). We used a Pvalue of 0.01 to declare any given construct as depleted in the post-testis
library. In order to reduce the chance of off-target effects, we used the
standard RNAi screen requirement that any given gene has to have two
different signiﬁcantly depleted shRNAs before declaring that gene as
essential for spermatogenesis. Given the low multiplicity of infection of
our transfection system, the fold changes of each shRNA construct
should be independent random variables under the null hypothesis that
there is no relationship between shRNA expression and germ cell survival. Thus, the probability of observing a gene with two depleted
shRNA constructs should be 1 · 1024 or (0.01)2.
Next, we set out to estimate the false negative and false positive rate of
our shRNA screening system when using this “two-hit” criterion. Of
17 positive control genes, 14 were identiﬁed as required for spermatogenesis, producing an estimate of 18% for the false negative rate of our
approach (Figure 4A). The positive controls that did not show signiﬁcant
depletion were BAX, MATP7, and SH2B1. These false negatives could not
be simply attributed to low sequence coverage, as the average coverage of
constructs for each gene was 6188X, 1732X, and 1163X, respectively. Five
out of ﬁve (100%) BAX constructs were experimentally validated to knock
down expression; likewise four out of ﬁve of the MTAP7 and ﬁve out of
ﬁve of the SH2B1 constructs were experimentally validated. One of the
eight negative control genes, TNFSF4 (which is moderately expressed in
the testes) was also signiﬁcantly depleted, producing a conservative false
positive rate estimate of 12.5% (one out of eight). Some positive control
constructs (14/83 or 17%) showed statistically signiﬁcant enrichment; this
could be due to off-target effects or, more likely, an artifact due to the way

Figure 3 shRNA screening assays are highly reproducible and tissue-speciﬁc. We performed numerous biological replicates of the pilot library
screening on testis (n = 9) and the N2a neuronal cell line (n = 15). (A) Comparison of two biological replicates within the testis. For each replicate,
we summarize the frequency of all 119 shRNA constructs as the log2 ratio of testis frequency/input library frequency. Overall, the concordance of
fold changes between these two replicates is high (Spearman R = 0.94). While 11% of negative control constructs show negative fold changes in
both biological replicates, all of these correspond to genes expressed in testis. On the other hand, 35% of positive control constructs show
negative fold changes. (B) Comparison of two biological replicates of the screen in N2a cells shows the screen is also highly reproducible in this
cell population (Spearman R = 0.89). The variance in fold change among constructs is visibly smaller in the N2a experiments when compared to
the testis; this is likely due to higher transfection efﬁciency in N2a cells. (C) As a broader summary of screen reproducibility, we calculated
Spearman correlations between all pairs of biological replicates for testis (black line) and N2a cells (blue line), as well as all possible pairs of N2a
and testis replicates (red). Biological replicates of the same source tissue were highly correlated (median Spearman R for N2a–N2a comparisons =
0.81, dashed blue line; testis–testis = 0.83, dashed black line). However, screen results from different sources showed substantially lower
correlation (median Spearman R = 0.56, dashed red line). This anticorrelation was largely driven by “negative control” shRNAs showing depletion
in N2a cells, as well as neutral behavior of positive controls in N2a cells. shRNA, short hairpin RNA.

we normalized the shRNA count data to account for heterogeneity in
transfection efﬁciency (see File S4 for more details).
One drawback of our screening strategy is that the genes we identify
could be required speciﬁcally in spermatogenesis, or just for the general
survival of all cells. We reasoned that it should be possible to disentangle
these two effects by transfecting the same shRNA pool into an unrelated
cell line and performing a survival screen on the cells. Genes required for
general cell survival will be identiﬁed by both screens, while genes with
germ-cell speciﬁc function will not.
We transfected three separate batches of Neuro-2a (N2a) cells, and
cultured these for 12 d, in an attempt to match the number of cell
divisions that would occur during spermatogenesis (Drost and Lee
1995). The cells were passaged a total of ﬁve times over this 12 d period.
At each passage, we sampled genomic DNA from each culture, prepared sequencing libraries, and analyzed the data through the same
pipeline as the testis samples (Materials and Methods). As with the
testis libraries, there was robust correlation in shRNA fold changes
among biological replicates (Figure 3B). Interestingly, the shRNA fold
changes in the N2a library showed a substantially lower correlation
with the testis library fold changes, indicating that we do indeed observe
tissue-speciﬁc selection in our screen (Figure 3C). This reduced correlation was largely driven by “negative control” shRNAs showing depletion in N2a cells, as well as neutral behavior of positive controls in
N2a cells. Furthermore, only two of the shRNA sets that were signiﬁcantly depleted in the testes samples were also signiﬁcantly depleted in
the cell lines SIRT1 and CPEB1 (Figure 4A). Thus, we concluded that
the genes with multiple shRNAs depleted in testes are often essential for
germ cell development and not just general cell viability.
Screening for uncharacterized predicted fertility genes
We previously developed a computational algorithm to predict genes
required for spermatogenesis (Ho et al. 2015). For each gene in the

mouse genome, this algorithm uses high-throughput genomic data to
report a probability that the gene is required for spermatogenesis.
While we have benchmarked the performance of this method by comparison with genes known to be irrelevant or essential for sperm production, we never experimentally validated any of our novel
predictions. We designed a new shRNA pool against the top 26 genes
from our computational screen that had no known role in spermatogenesis (Materials and Methods). The new shRNA pool comprised
130 shRNAs against the candidate genes and 15 negative control
shRNAs. These candidates display a variety of expression signatures
in spermatogenesis: four genes begin expression early in spermatogenesis (ALPI, POLA1, RFC1, and RRM1), 15 genes begin expression in
the middle of spermatogenesis (CRISP2, GSTM5, HRASLS5, KLHDC3,
LDHAL6B, PGAM2, PHF7, PHKG2, RFC2, SFI1, SPATA4, TAF9,
TCP1, TCP11, and ZMYND10), and seven genes are only expressed
late in spermatogenesis (4933411K16Rik, ACTL7B, GSG1, MEA1,
SPA17, SPZ1, and UGT1A1) (see Table S1).
Similar to the pilot screen, the SE in shRNA frequencies estimated
from technical replicates indicated strong reproducibility (Pearson
correlations 0.54–0.96) and low experimental noise. None of the 15 negative control shRNAs were signiﬁcantly depleted (P # 0.01) while all of
the 26 candidate genes had at least two shRNAs targeting them that
were signiﬁcantly depleted in the testes samples (Table S4). A few genes
even had up to four different signiﬁcantly depleted shRNAs (P # 0.01)
(Figure 4B). Similar to the pilot pool, we also transfected this pool into
N2a cells to eliminate the possibility that these genes are required for
general cell survival. Overall, the normalized read counts of the shRNA
pool in N2a cells were not well correlated with the testis read counts
(Figure 4B). Two genes (SFI1 and SPA17) had two or more shRNAs
that were signiﬁcantly depleted (P # 0.01). Given this, we concluded
that most of the predicted genes (21/26) affect spermatogenesis and not
survival.
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Figure 4 shRNA screen results. Overview of the full screening results for (A) the pilot shRNA pool and (B) the predicted genes shRNA pool. Each
row of the heatmap summarizes the screening data for constructs targeting a single gene that were transfected into either testis (left heatmap) or
N2A cells (right heatmap). Each cell shows the log2 fold change of a single shRNA construct when comparing frequencies from the transfected
tissue to the input pool frequencies. Constructs with signiﬁcant depletion or enrichment in testis or N2a cells are encased in a hatched box; boxes
with white hatching represent enrichment compared to the input pool and boxes with orange hatching represent depletion. The constructs within
each row are sorted left-to-right in ascending order based on the log2 fold change. In (A), the genes are further organized into functional
categories as indicated by the color bar to the left of the heatmaps, and in (B) genes are also organized based on cell type of peak expression
level, with stages encoded by the color bar. shRNA, short hairpin RNA.

Design of future screens
Given the strong results obtained with our ﬁrst two shRNA screening
experiments, we believe there is great potential for this approach moving
forward. In order to improve the design of future screening experiments,
we reanalyzed all of the sequencing data generated from our pilot screen
to characterize the relationship between both (a) the number of biological replicates performed and (b) the number of constructs screened
and the power to detect signiﬁcant depletion of shRNAs against a typical
positive control gene. To address (a), we estimated the fraction of
positive control genes detected as signiﬁcantly depleted as a function
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of the number of biological replicates. To address (b), we estimated the
fraction of positive control genes detected as signiﬁcantly depleted as a
function of sequencing coverage for each library. As in our initial
analyses, we required that two shRNAs for the same gene should be
shown to be signiﬁcantly depleted in order to declare a gene as a “hit” in
the screen.
Increasing the number of biological replicates provides more conﬁdence that the RNAi fold changes are biologically signiﬁcant, but we
observed diminishing returns with increasing numbers of replicates. For
lenient (P , 0.1), standard (P , 0.05), and stringent (P , 0.01) P-value

cutoffs there was little improvement in detectable RNAi fold change
beyond 3–4, 4–5, and 6–7 biological replicates, respectively (Figure 5A).
Each shRNA construct was allocated an average of 5000 sequencing
reads in our actual experiments. When using nine biological replicates,
we found that we could have reduced the average read coverage to
250 reads per construct without any loss of power, and that 70% power
could be maintained to even ﬁve reads per construct (Figure 5B). Further
reducing average coverage rapidly and drastically reduces power.
DISCUSSION
The combination of multiplex genetic manipulation and high-throughput phenotyping presents incredible opportunities for studying the
genome biology and evolution of the mammalian germline. Here, we
have presented a method that opens the door to in vivo genomic
experiments in mammalian testis and have demonstrated its utility
by performing multiplex shRNA screens for genes essential to spermatogenesis. The performance of our direct in vivo screen is comparable to other benchmarked RNAi screens performed in other model
systems. Our false negative rate of 18% is up to the standards of various
studies benchmarking RNAi screens for different pathways in Drosophila melanogaster (DasGupta et al. 2007; Liu et al. 2009; Booker et al.
2011; Hao et al. 2013), where it was reported to be between 13 and 50%.
Our false positive rate of 12.5% also compares favorably to the same
study (Liu et al. 2009), which found their false positive rates to be
between 7 and 18%. Since it is not fully understood how RNAi sequence
affects knockdown efﬁciency, these false positive and negative rates are
to be expected due to off-target effects and noneffective RNAi, respectively. This is why we observed variable (sometimes contrasting) fold
changes for different RNAi purportedly targeting the same gene, although each RNAi has a consistent observed fold change.
As it stands, the technique produces strongly reproducible results but
several aspects of the system could be improved. The key limitation is
transfection efﬁciency. In vivo transfection rates tend to be orders of

magnitude lower than in vitro systems for the same transfection reagent
(Li and Huang 2000). This leads to trade-offs between the size of the
screening library, the number of biological replicates, and the cost of the
transfection reagent. To avoid the issue of low transfection rates in
other tissues, some groups have transfected cells in vitro and then
transplanted them into recipient mice and performed screening in
the xenografted models (Zender et al. 2008; Bric et al. 2009;
Meacham et al. 2009; Zuber et al. 2011a). In principle, this may work
for male germ cells, as spermatogonial stem cells have been transplanted into sterile donor testes to restore fertility in various species
(Brinster and Zimmermann 1994; Ryu et al. 2007). In practice, this
stem cell transplantation is a difﬁcult technique to perform and a low
number of unique stem cells successfully transplant per mouse. This
creates a bottleneck that makes cell transplantation inappropriate for a
screening study, since screening relies on having a large number of
independent transfection events in order to produce statistically significant results. More technically challenging protocols, such as efferent
duct injection or in vitro organogenesis, could enhance transfection
efﬁciency. It could also be possible to use experimental evolution to
generate new viral serotypes with high trophism for testis.
We were extremely conservative with the multiplexity of the pool in
this study. In order to avoid dropout of individual constructs and
produce reproducible signals, we ensured that the number of cells
transfected was orders of magnitude larger than the number of shRNAs.
In this manner, we could be conﬁdent that no shRNA would be
underrepresented in the ﬁnal pool due to transfection efﬁciency. Even
with a transfection rate of 1–5%, we were able to obtain consistent
signals using pools consisting of up to 150 shRNAs. It is estimated
that there are a total of 108 cells in the adult murine testis (Tegelenbosch
and de Rooij 1993). With a transfection efﬁciency of 1%, 106 cells
should receive constructs, suggesting that in our pilot experiment, each
of our 119 unique shRNA constructs infected an average of 8403 cells.
Conservatively, if we require that each construct transfects

Figure 5 Inﬂuence of experimental design parameters on the power of the screen. We reanalyzed all of the sequencing data generated from our
pilot screen to characterize the relationship between the number of biological replicates performed, the number of constructs screened, and the
power to detect signiﬁcant depletion of shRNAs against a typical positive control gene. (A) As the number of biological replicates increases,
the minimum detectable shRNA fold change (i.e., effect size) decreases. The three lines indicate the median minimum log2 fold change that was
declared as signiﬁcant at a threshold of P # 0.1 (yellow), P # 0.05 (red), and P # 0.01 (blue). The shaded area around each line deﬁnes a 1 SD
conﬁdence interval. Note that the blue line starts at three biological replicates because there were no signiﬁcant observations with two or fewer
replicates. (B) Power to detect a positive control gene as signiﬁcantly depleted increases with increasing average read coverage of each shRNA
construct. The average coverage and power of the full pilot experiment is indicated with a red dot. shRNA, short hairpin RNA.
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100 independent cells, we could increase the scale of the screen to
10,000 constructs. This would allow a screen of 2000 genes with ﬁve
constructs per gene.
Another limitation of the present study is that our transfection
approach is not able to target speciﬁc cell types; this presents challenges
for the interpretation of screen results and confounds our ability to
identify the function of genes with stage-speciﬁc effects on spermatogenesis. A simple way to address this limitation of “off-target” transfection would be to make shRNA constructs expressed by an inducible
promoter (e.g., Cre) and transfect the library into an animal expressing
the inducer in a stage-speciﬁc manner (e.g., a Vasa-Cre or Stra8-Cre
animal).
As a proof-of-principle, we used our screening system to test 26 genes
that we previously predicted as being essential for spermatogenesis. We
validated all 26, which is remarkable, but also consistent with the fact that
these were selected as the highest ranked (but unknown) spermatogenesis genes from over 1000 possible candidates. There are diverse
molecular functions represented in this set of 26. Seven genes are
thought to be involved in DNA replication and chromatin dynamics
(ACTL7B, KLHDC3, POLA1, RFC2, RFC4, RRM1, and SFI1), seven in
metabolism (ALPI, GSTM5, HRASLS5, LDHAL6B, PGAM2, PHKG2,
and UGT1A1), four transcription factors (OHF7, SPZ1, TAF9, and
ZMYND10), two in protein folding (TCP1 and TCP11), one in cell
binding in sperm (SPA17), and one involved in capacitation of the
membrane (CRISP2). In order to better understand our ascertainment,
we visualized the functional relationships of these candidate genes with
other known spermatogenesis genes (see Figure S3). Most of the candidates were related through a single large network of interactions but,
interestingly, all seven candidates implicated in DNA replication and
chromatin dynamics were related by a smaller, standalone network that
has yet to be characterized in testis. Also noteworthy were the three
genes of unknown molecular function: 4933411K16Rik, GSG1, and
SPATA4. These genes could work in novel pathways, providing new
insights about spermatogenesis.
Beyond its use as a validation tool, there are many potential
applications of testis shRNA screening. During this project, we attempted to enhance the characterization of our target genes by performing
additional screens that use cell stage or functional separation (via FACS
and sperm motility assays, respectively). Unfortunately, because the
number of cells we could retrieve in this manner was limited, we were
unable to prepare sequencing libraries from the subpopulations. If we
could transfect a majority (60–80%) of the cells, or if it was possible to
sort and retrieve large numbers of cells (10 sec of millions), direct
functional assays using an RNAi pool may be possible. There are many
mysterious aspects of germ cell development and function that could be
rapidly screened when in vivo transfection becomes more efﬁcient.
What are the causes and consequences of germ cell epimutation? What
are the determinants of sperm morphology, and why is sperm morphology so variable within a single ejaculate? Is the extensive transcription of noncoding DNA during spermiogenesis functional, or is it just
an epiphenomenon? Finally, there are also numerous translational applications for this technique, as a tool for validating diagnoses made
from medical sequencing data or for developing highly speciﬁc male
contraceptives.
Here, we have reported a novel in vivo screening method to characterize the function of genes in the mammalian testis, and used it to
validate 26 candidate genes as essential for spermatogenesis. It would
have been impossible for our group to generate the same experimental
evidence for these candidates using conventional single-gene mouse
models. We have provided experimental protocols (see File S1 and File
S2) and an analysis pipeline (see File S3) to enable other interested
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groups to apply this screening technique to their own questions of
interest.
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